Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06346340
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-03-28
Brief Title:
A Study to Evaluate the Effect of Miebo on Preoperative BiometryKeratometry and Postoperative Refractive Accuracy
Sponsor:
Bausch Lomb Incorporated
Organization:
Bausch Lomb Incorporated
Study Overview
Official Title:
A Phase 4 Multicenter Open-Label Study to Evaluate the Effect of Miebo on Preoperative Biometry Keratometry and Postoperative Refractive Accuracy
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase 4 Multicenter Open-Label Study to Evaluate the Effect of Miebo on Preoperative Biometry Keratometry and Postoperative Refractive Accuracy
Detailed Description:
The primary objective is to determine the effect of preoperative Miebo treatment on the accuracy of preoperative biometrykeratometry and predicted refraction in subjects with dry eye disease DED who are already scheduled for cataract surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None